These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5111310)

  • 41. Delta-aminolevulinic acid synthetase and adenosine triphosphate activity in acute saturnine intoxication in rabbits.
    Gajdos A; Gajdos-Török M
    Arch Environ Health; 1971 Oct; 23(4):270-4. PubMed ID: 5111309
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in porphyrins metabolism in experimental poisoning with increasing doses of lead].
    Pecora L; Rossi A; Brancaccio A
    Folia Med (Napoli); 1967 Dec; 50(12):899-910. PubMed ID: 5617898
    [No Abstract]   [Full Text] [Related]  

  • 43. Interrelationships between lead in blood, lead in urine, and ALA in urine during lead work.
    Selander S; Cramér K
    Br J Ind Med; 1970 Jan; 27(1):28-39. PubMed ID: 5418917
    [No Abstract]   [Full Text] [Related]  

  • 44. Absorption and excretion of mercury in man. 13. Effects of mercury exposure on urinary excretion of coproporphyrin and delta-aminolevulinic acid.
    Goldwater LJ; Joselow MM
    Arch Environ Health; 1967 Sep; 15(3):327-31. PubMed ID: 6035082
    [No Abstract]   [Full Text] [Related]  

  • 45. [Quantitative determination of 5-aminolevulinic acid in plasma and urine in the course of some primary and secondary erythrocytopathies].
    DANIELI G; SANGIORGI F; MASETTI GP
    Folia Med (Napoli); 1962 Oct; 45():853-65. PubMed ID: 14024932
    [No Abstract]   [Full Text] [Related]  

  • 46. [Production of porphobilinogen from delta-aminolevulinic acid with cell suspensions from Propionibacterium shermanii].
    Müller G; Bezold G
    Z Naturforsch B; 1969 Jan; 24(1):47-53. PubMed ID: 4388877
    [No Abstract]   [Full Text] [Related]  

  • 47. [Methods of prevention of lead poisoning in the light of clinical and laboratory data].
    Petrović L
    Arh Hig Rada Toksikol; 1969; 20(4):661-4. PubMed ID: 5203150
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lead and delta-aminolevulinic acid in urine: quality control].
    Grisler R; Gobbi A; Colombo G; Colombo R; Valla C
    Med Lav; 1974; 65(5-6):202-5. PubMed ID: 4456167
    [No Abstract]   [Full Text] [Related]  

  • 49. Recent progress in the studies of lead poisoning.
    Wada O; Oi G
    Rev Environ Health; 1972; 1(1):75-111. PubMed ID: 4139736
    [No Abstract]   [Full Text] [Related]  

  • 50. [Porphyrin metabolism in chronic lead poisoning, anemia and non-lead liver diseases].
    Saita G; Moreo L; Croce G
    Med Lav; 1966 Mar; 57(3):167-74. PubMed ID: 5985036
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on the varying lead load among the population of Vienna and Bandung (Indonesia) as characterized by the excretion of urinary 5-aminolevulinic acid. (6. Toxic substance load and preventive examination)].
    Maruna H; Wibisono W; Maruna RF; Altmann P
    Wien Med Wochenschr; 1976 May; 126(20-22):305-7. PubMed ID: 63184
    [No Abstract]   [Full Text] [Related]  

  • 52. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
    Alessio L; Bertazzi PA; Cortona G
    Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
    [No Abstract]   [Full Text] [Related]  

  • 53. [A method for screening of lead exposure using spot urine sample based on relationship between delta-ALA and creatinine excretion (author's transl)].
    Nishima T
    Nihon Eiseigaku Zasshi; 1977 Jun; 32(2):398-405. PubMed ID: 916314
    [No Abstract]   [Full Text] [Related]  

  • 54. [Anemia in saturnism. Apropos of 3 cases].
    Najman A; Fabiani G; Protin P; Buneaux F; Duhamel G; André R
    Ann Med Interne (Paris); 1972 Nov; 123(11):901-8. PubMed ID: 4633580
    [No Abstract]   [Full Text] [Related]  

  • 55. The renal handling of delta-aminolevulinic acid in normal and lead-poisoning rabbits.
    Johnson DR; Foulkes EC; Hammond PB
    Toxicol Appl Pharmacol; 1976 Oct; 38(1):101-9. PubMed ID: 982461
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of some parameters of lead exposure and possible correlation between them.
    Soliman MH; El-Sadek YM; El-Kashlan KM; Gabr Y; El-Waseef A
    J Egypt Med Assoc; 1976; 59(5-6):469-80. PubMed ID: 1032315
    [No Abstract]   [Full Text] [Related]  

  • 57. Species difference of urinary excretion of delta-aminolevulinic acid and coproporphyrin in mice and rats exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y
    Toxicol Lett; 1988 Jun; 41(3):255-9. PubMed ID: 3376152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Formulation of biological indexes for epidemiological studies of exposure to lead poisoning].
    Borghetti A; Cavatorta A; Dal Canton A; Franchini I; Neri TM; Novarini A
    G Clin Med; 1971 Mar; 52(3):234-46. PubMed ID: 5121119
    [No Abstract]   [Full Text] [Related]  

  • 59. [Disorders of heme synthesis during anemia and chronic liver diseases].
    Sroczynski J; Urbanowicz H; Strynk M
    Sem Hop; 1968 Nov; 44(46):2819-26. PubMed ID: 4311293
    [No Abstract]   [Full Text] [Related]  

  • 60. Changes in hepatic delta-aminolevulinic acid in lead-intoxicated rats.
    Suketa Y; Aoki M; Yamamoto T
    J Toxicol Environ Health; 1975 Sep; 1(1):127-32. PubMed ID: 810598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.